GBA1 and Parkinson disease: Accumulation of glucosylceramide in lysosomes may contribute to lysosomal dysfunction for homozygous GBA mutations but no evidence of glucosylceramide accumulation in PD brains with heterozygous GBA mutations has been reported20.